American Journal of Kidney Diseases
Volume 55, Issue 2 , Pages 250-258, February 2010

Prediction of ESRD in Pauci-immune Necrotizing Glomerulonephritis: Quantitative Histomorphometric Assessment and Serum Creatinine

  • Clara J. Day, BMBCh, PhD

      Affiliations

    • Department of Nephrology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  • ,
  • Alec J. Howie, MD

      Affiliations

    • Department of Pathology, University College London, UK
  • ,
  • Peter Nightingale, PhD

      Affiliations

    • Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
    • Corresponding Author InformationAddress correspondence to Peter Hewins, MBChB, PhD, University of Birmingham, Division of Immunity and Infection, Medical School, Birmingham, West Midlands B15 2 TT, UK
  • ,
  • Shazia Shabir, MBChB

      Affiliations

    • Department of Nephrology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  • ,
  • Dwomoa Adu, MD

      Affiliations

    • Department of Nephrology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
  • ,
  • Caroline O. Savage, FMedSci

      Affiliations

    • School of Immunity & Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
  • ,
  • Peter Hewins, MBChB, PhD

      Affiliations

    • Department of Nephrology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
    • School of Immunity & Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

Received 6 May 2009; accepted 28 September 2009. published online 04 January 2010.

Background

Clinical and pathologic features that predict outcome have important potential application in patients with pauci-immune necrotizing glomerulonephritis (usually antineutrophil cytoplasmic antibody–associated vasculitis). This study examines the predictive value of simple quantitative renal histologic measurements in a large cohort with extended follow-up.

Study Design

Cohort study.

Setting & Participants

390 consecutive patients with pauci-immune necrotizing glomerulonephritis at a single hospital (1983-2002); 90 patients underwent repeated kidney biopsy during follow-up.

Predictors

Age and serum creatinine concentration at biopsy, antineutrophil cytoplasmic antibody specificity, percentage of normal glomeruli, percentage of glomeruli with active lesions, and index of chronic damage (quantitative measurement of established cortical damage) in the initial kidney biopsy for all patients. The same factors were assessed in both biopsy specimens for patients undergoing an additional biopsy.

Outcomes & Measurements

End-stage renal disease and patient survival.

Results

Mortality at 1 and 5 years was 23% and 40%, respectively: standardized mortality ratio, 4.74 (95% CI, 3.62-6.32). End-stage renal disease was reached by 14% and 18% at 1 and 5 years, respectively. In multivariable analysis, serum creatinine level at biopsy and percentage of normal glomeruli in the initial biopsy specimen were the best predictors of kidney survival. C Statistics were 0.80 for creatinine level alone and 0.83 for creatinine level with normal glomeruli. In patients undergoing an additional biopsy, rapid progression in the index of chronic damage and serum creatinine level at the second biopsy were associated with kidney survival in multivariable analysis.

Limitations

Retrospective analysis. External validity of the index of chronic damage requires further assessment. Selection bias may influence repeated biopsy analyses.

Conclusions

Serum creatinine level at biopsy best predicts kidney survival in patients with pauci-immune necrotizing glomerulonephritis overall.

Index Words: Vasculitis, necrotizing glomerulonephritis, antineutrophil cytoplasm autoantibody, kidney biopsy, end-stage renal disease (ESRD)

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Originally published online as doi:10.1053/j.ajkd.2009.10.047 on January 4, 2010.

PII: S0272-6386(09)01445-0

doi:10.1053/j.ajkd.2009.10.047

American Journal of Kidney Diseases
Volume 55, Issue 2 , Pages 250-258, February 2010